AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,714,250 | -28.9% | 325,000 | -26.9% | 0.05% | -24.6% |
| Q2 2023 | $31,935,806 | -50.7% | 444,417 | -57.7% | 0.07% | -52.4% |
| Q1 2023 | $64,764,000 | -21.2% | 1,050,000 | -1.4% | 0.14% | -26.0% |
| Q4 2022 | $82,143,450 | +1127.3% | 1,065,000 | +610.0% | 0.20% | +1052.9% |
| Q3 2022 | $6,693,000 | -77.7% | 150,000 | -80.9% | 0.02% | -75.4% |
| Q2 2022 | $30,014,000 | +11.6% | 783,662 | +20.6% | 0.07% | +35.3% |
| Q1 2022 | $26,904,000 | +88.8% | 650,000 | +225.0% | 0.05% | +41.7% |
| Q3 2020 | $14,250,000 | -13.4% | 200,000 | 0.0% | 0.04% | -14.3% |
| Q2 2020 | $16,456,000 | +229.1% | 200,000 | +135.3% | 0.04% | +180.0% |
| Q1 2020 | $5,001,000 | – | 85,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |